Autori: Cutrona C

Filtra

Data

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis

Torna in alto